The development of fatigue after treatment for pediatric brain tumors does not differ between tumor locations.
Elin IrestormAntoinette Y N Schouten-van MeeterenMarloes van GorpJos W R TwiskHanneke M van SantenMarita PartanenMartha A GrootenhuisRaphaele R L van LitsenburgPublished in: Pediatric blood & cancer (2024)
The development of fatigue seems to be more related to sociodemographic and treatment variables than to tumor location. Healthcare providers need to be aware that fatigue may develop in the years following end of treatment, and that patients with a low/middle educational family background might be more vulnerable and in need of targeted support.